Does anyone know if the specific guidelines and test parameters are available on the PAR website? Also, in reference to the following paragraph regards Compliance manufacturing: ”Paradigm contracted Siegfried Hameln a leader of pharmaceutical drug manufacturing to develop GMP production of ZilosulÒ, Paradigm’s drug using iPPS to treat OA. A manufacturing process has been successfully established to provide commercial quantities of ZilosulÒ, and drug product from these production runs will be used in the upcoming pivotal phase 3 trials.” Now as I understand it Zilusol is a PAR modified product manufactured by Siegfried Hameln from that supplied by BENI to PAR, is this correct?
PAR Price at posting:
$1.40 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)